<p>Our lab has identified and validated novel metabolite profiles of those destined to develop overt T2D. These metabolites were elevated up to 12 years before the onset of T2D in  individuals who were initially glucose-tolerant; improved prediction of T2D beyond clinical risk factors and established biochemical markers; and</p>

Metabolomic Predictors of Insulin Resistance and Diabetes

Metabolomics study on BDC (2,706 participants)